Large-Scale Study Validates Multi-Cancer Blood Test Performance
A real-world study of 111,080 participants found the Galleri multi-cancer blood test achieved a 0.91% cancer detection rate and 87% accuracy in predicting tumor origin.
Read More
Search Results for: liver disease
Tempus Launches AI-Powered Digital Pathology Suite for Biomarker Prediction
Tempus has introduced Paige Predict, an AI-powered pathology suite that analyzes H&E slides to predict 123 biomarkers across 16 cancer types when tissue samples are insufficient.
Read More
HistoIndex Partners with Houston Research Institute for MASH Diagnostic Services
HistoIndex and Houston Research Institute have partnered to offer AI-driven pathology analysis for metabolic dysfunction-associated steatohepatitis across four HRI centers in Texas, expanding advanced diagnostic services for liver disease.
Read More
bioMérieux Acquires Accellix for Cell and Gene Therapy Quality Control
bioMérieux has acquired Accellix for about €35 million, adding rapid, automated flow cytometry to its pharmaceutical quality control portfolio for cell and gene therapy manufacturing.
Read More
Plasma Test Launches for Rapid Detection of Mold Infections
The plasma-based test detects cell-free DNA from 14 mold species and delivers results in less than 24 hours, according to the company.
Read More